Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Catalent appoints Ricardo Pravda to lead human resources function
Catalent appoints Ricardo Pravda to lead human resources function
Pravda succeeds Lance Miyamoto who retired on 30 June, and is currently serving as an adviser to the company
Romil creates new UK National Sales Manager position
Romil creates new UK National Sales Manager position
Paul Stubbings will start in the position to allow Sales Director Anthony Lenk to dedicate more time to the company’s rapidly growing direct sales and distributor-based...
Nanoform appoints new head of investor relations
Nanoform appoints new head of investor relations
Henri von Haartman will be the company’s new Director of Investor Relations
Verona Pharma makes two senior appointments
Verona Pharma makes two senior appointments
Nina Church joins as Executive Director of Global Clinical Development and Nancy Herje as Senior Director of Clinical Operations
Mereo BioPharma appoints Head of Pharmaceutical Development
Mereo BioPharma appoints Head of Pharmaceutical Development
Cambrex makes three senior appointments
Cambrex makes three senior appointments
Bruno Biscaro has been appointed President of Drug Products, Joe Nettleton as President of Drug Substance, and Simon Edwards as President of CDMO Sales & Marketing
The Marchesini Group appoints new Sales Director
The Marchesini Group appoints new Sales Director
Francesco Stanzani will start his new role with immediate effect based in Pianoro
Medherant appoints new CEO
Medherant appoints new CEO
John Burt will replace Current CEO, Nigel Davis, who will stay on as Chief Business Officer
Connect 2 Cleanrooms appoints new MD and CEO
Connect 2 Cleanrooms appoints new MD and CEO
Michael Wright will succeed founding MD Joe Govier who has moved to the CEO role
Ex-FDA Commissioner joins Pfizer
Ex-FDA Commissioner joins Pfizer
Scott Gottlieb will also be a part of the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s Board
Newcomer Quell Therapeutics appoints Iain McGill as CEO
Newcomer Quell Therapeutics appoints Iain McGill as CEO
The company was founded in March 2019, in a partnership between prominent experts from King's College London, University College London, and Hannover Medical School
Dr Bartu Ahiska is new Senior VP at Oxford BioDynamics
Dr Bartu Ahiska is new Senior VP at Oxford BioDynamics
In his new role Ahiska will spearhead the commercialisation of the group’s EpiSwitch technology platform
Domain Therapeutics adds Sylvie Ryckebusch to Board
Domain Therapeutics adds Sylvie Ryckebusch to Board
Ryckebusch joins Domain from Merck Serono
Symbiosis Pharmaceutical Services appoints Helen Caddy-Leach
Symbiosis Pharmaceutical Services appoints Helen Caddy-Leach
Caddy-Leach will take on the role of Business Development Manager to support growing US presence
MG America appoints Janice Wortham as Regional Sales Manager
MG America appoints Janice Wortham as Regional Sales Manager
Wortham will cover the Processing division covering some on the most important pharma stronghold in the US
ReViral appoints Alex Sapir as new CEO
ReViral appoints Alex Sapir as new CEO
Sapir will be based at North Carolina’s Research Triangle Park alongside the company’s new CMO, Seth Hetherington
Previous
1
…
34
35
36
37
(current)
38
39
40
…
214
Next
Trending Articles
Alfa Laval appoints new managing director to drive strategic growth
Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
How strong leadership transforms regulatory and operational challenges
Why SLTs fail on the PQS/QMS: The leadership gap undermining quality
Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors
A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
Kindeva appoints Brok Weichbrodt as Chief Transformation Officer to accelerate growth strategy and commercial excellence
Kindeva, a global drug delivery Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and accelerate growth as the company enters the next phase of its value creation plan
Medicines Discovery Catapult selects prominent UK life sciences leader, Professor Sir Mike Ferguson, as its incoming Chair of the Board
MDC welcomes new Chair from January 2027 to drive impact as next-generation technologies and collaborations reshape drug discovery
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all